the importance of improving precision when risk stratifying patients with multiple myeloma
Published 1 year ago • 90 plays • Length 0:43Download video MP4
Download video MP3
Similar videos
-
3:59
the importance of accurately defining high-risk myeloma and current risk stratification systems
-
4:51
risk stratification & treatment of multiple myeloma precursor conditions
-
3:05
recent advances in newly diagnosed multiple myeloma and the importance of patient perspectives
-
1:16
the importance of risk-stratifying treatment for multiple and smoldering myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
12:26
treating ultra high risk myeloma patients in a unique uk study | martin kaiser, md | ash 2021
-
9:25
mgus diagnosis: a step-by-step approach
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
2:45
an insight into clinical risk factors for progression in mpns
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
4:01
kenneth anderson: what are the next steps to a myeloma cure?
-
2:13
founding precision therapy for 1q-amplified multiple myeloma
-
1:44
optimal treatment sequencing in multiple myeloma
-
1:01
car-t: myeloma toxicities
-
1:40
utilizing ai for individualized treatment-adjusted risk stratification in newly diagnosed myeloma
-
2:10
managing mm patients through multiple lines of therapy: risk vs benefit
-
1:56
defining the optimal duration of maintenance therapy for multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
5:33
the importance of tailored treatment approach in multiple myeloma
-
1:46
changes in the myeloma treatment paradigm